Steering Committee

Jason D. Bloom, MD, FACS
Adjunct Assistant Professor
Department of Otorhinolaryngology: Head & Neck Surgery
University of Pennsylvania
Philadelphia, PA
Clinical Assistant Professor (Adjunct)
Department of Dermatology
Temple University School of Medicine
Philadelphia, PA
Owner
Bloom Facial Plastic Surgery
Bryn Mawr, PA  

Rachel Pritzker, MD, FAAD
Chicago Cosmetic Surgery and Dermatology
Chicago, IL
 

Target Audience 

This activity has been designed to address the educational needs of residents and fellows in aesthetic medicine, including dermatology, dermatological surgery, cosmetic surgery, plastic surgery, facial plastic surgery, ophthalmology, oculoplastic surgery, and otolaryngology.
 

Educational Provider

This activity is provided by Paradigm Medical Communications, LLC.  
 

Supporter Acknowledgment 

This activity is supported by an educational grant from AbbVie Inc.    

This activity is supported with in-kind contributions: 
AbbVie Inc. – other (injectable fillers) and (botulinum toxin vials)
 

Program Overview 

Aesthetic patients, increasingly educated and diverse, are seeking nonsurgical facial rejuvenation with hyaluronic acid (HA) soft tissue fillers and neuromodulators, driving the need for accurate assessment of relevant anatomy, understanding of agent characteristics, and state-of-the-art techniques that facilitate natural, individualized outcomes. This initiative was devised to assist residents and fellows who intend to practice aesthetic medicine gain the expertise and technical abilities necessary to provide excellent results for all patients.
 

Learning Objectives

Upon completion of this activity, participants should be able to:

• Review the anatomy and pathophysiology of the aging face, including skin laxity and volume loss, in a diverse patient population as they relate to facial rejuvenation with a combination of nonsurgical injectable therapies
• Differentiate currently available HA soft tissue fillers and neuromodulators for nonsurgical aesthetic facial rejuvenation based on the most recent data regarding pertinent clinical characteristics 
• Develop individualized treatment plans for safe and effective facial rejuvenation in a diverse patient population using HA soft tissue fillers and neuromodulators based on anatomic assessment, patients’ goals, and agent characteristics

Physician Accreditation Statement

Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 

Physician Credit Designation Statement

Paradigm Medical Communications, LLC designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
 

Instructions for Participation

To receive a certificate of participation, participants must:
•    Follow instructions to register or log in with your professional information and complete the preassessment  
•    Attend the live event in its entirety
•    Complete and return the activity postassessment, evaluation, and request for credit forms to a Paradigm staff member as you exit

A certificate of participation will be issued 1 to 2 weeks following the meeting.

For questions regarding CME credit, contact the Paradigm CME Department at cme@paradigmmc.com.

There are no fees for participating in this activity.
 

Disclosure of Relevant Financial Relationships

In accordance with the Accreditation Council for Continuing Medical Education’s (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Paradigm requires that all planners, faculty, and others who are in a position to control the content of this activity disclose all financial relationships with ineligible companies during the past 24 months.

All relevant relationships are identified and mitigated according to Paradigm policy prior to individuals assuming their roles, and are disclosed prior to learners’ engagement in the activity. Paradigm is committed to providing learners with high-quality accredited continuing education that promotes improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. 

The content of this activity was independently reviewed to ensure that it is fair and balanced, scientifically rigorous, evidence based, and aligned with the public interest. All relevant relationships have been mitigated. 

Jason D. Bloom, MD, FACS
Advisor: Allergan Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.; Revance Therapeutics, Inc.; Suneva Medical
Consultant: Allergan Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.; Revance Therapeutics, Inc.; Suneva Medical
Speakers’ Bureau: Allergan Inc.; Galderma Laboratories, L.P.; Revance Therapeutics, Inc.; Sofwave
Independent Contractor: Allergan Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.; Teoxane Laboratories
Stocks: mend; Rion Aesthetics

Rachel Pritzker, MD, FAAD
Advisor: Allergan, Inc. (expired 2022); Galderma Laboratories, L.P. (expired 2022)

Paradigm Medical Communications, LLC staff members have no relevant financial relationships with ineligible companies to disclose.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.
 

Disclaimer

This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

As an ACCME-accredited provider, Paradigm Medical Communications, LLC must ensure that its activities include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. In this activity, the trade names for neuromodulators and soft tissue fillers are used for clarity. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC. 

© 2023 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.